TRUQAP 200 mg/1

TRUQAP 200 mg is a film-coated tablet containing capivasertib, used for targeted therapy. Learn about its uses, effects, and precautions here.

TRUQAP 200 mg is primarily used in targeted therapy to help manage certain types of cancer. Capivasertib, the active ingredient, works by targeting specific proteins involved in cell growth. This medication is often part of a broader treatment plan, including other therapies. Patients should consult their healthcare provider to understand what is TRUQAP 200 mg used for in their specific case.

Common effects of TRUQAP 200 mg may include fatigue, nausea, and diarrhea. Some users might experience changes in appetite or skin reactions. These effects can vary widely among individuals, and not everyone will experience them. It's important to monitor any side effects and discuss them with a healthcare professional.

TRUQAP 200 mg should be handled with care, following the prescribed dosage and administration guidelines. It is essential to store the medication properly and keep it out of reach of children. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Always follow the advice of a healthcare professional regarding the use of TRUQAP 200 mg.

TRUQAP 200 mg may interact with certain medications, including those that affect liver enzymes. Alcohol and other substances that impact liver function should be avoided. Patients should discuss all current medications with their healthcare provider to ensure safe use. It's crucial to be aware of potential interactions to prevent adverse effects.